Ischemic Heart Disease
Research Rundown – Episode 21: Hyperbaric Oxygenation Improves Redox Control & Reduces Mortality in the Acute Phase of Myocardial Infarction in a Rat Model

Research Rundown – Episode 21: Hyperbaric Oxygenation Improves Redox Control & Reduces Mortality in the Acute Phase of Myocardial Infarction in a Rat Model

As American Heart Month comes to an end, we want to share another piece of research that is proving Hyperbaric Oxygen will improve heart function when someone experiences a cardiac event, like a heart attack. Highlights: As with all research, this is where it...

Clinical Trial – Hyperbaric Oxygen Therapy in Patients With Chronic Stable Ischemic Heart Disease: An Option for Therapeutic Angiogenesis?

Hyperbaric oxygen therapy (HBOT) is proposed as a possible in vivo angiogenic stimulator for
improving microvascular myocardial perfusion and anginal symptoms as assessed by myocardial
perfusion imaging and angina questionnaire in patients with chronic stable ischemic heart
disease, when no other means to relief symptoms and/or ischemia are available.

Archives

Categories